| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.011 | 0.9 |